Aminoclay–lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption

References

• KawabataYWadaKNakataniMYamadaSOnoueSFormulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applicationsInt J Pharm201142011021884771
   PubMed Web of Science ®Google Scholar
• ChenHKhemtongCYangXChangXGaoJNanonization strategies for poorly water-soluble drugsDrug Discov Today20111636
   Google Scholar
• MosharrafMNyströmCThe effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugsInt J Pharm19951223547
   Web of Science ®Google Scholar
• SarnesAKovalainenMHäkkinenMRNanocrystal-based peroral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorptionJ Control Release201418010911624566254
   PubMedGoogle Scholar
• JinnoJKamadaNMiyakeMEffect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogsJ Control Release2006111566416410029
   PubMed Web of Science ®Google Scholar
• De WaardHHinrichsWFrijlinkHA novel bottom–up process to produce drug nanocrystals: controlled crystallization during freeze-dryingJ Control Release200812817918318423767
   PubMed Web of Science ®Google Scholar
• RegeBDKaoJPPolliJEEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayersEur J Pharm Sci20021623724612208453
   PubMed Web of Science ®Google Scholar
• PoutonCWPorterCJFormulation of lipid-based delivery systems for oral administration: materials, methods and strategiesAdv Drug Deliv Rev20086062563718068260
   PubMed Web of Science ®Google Scholar
• PoutonCWFormulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification systemEur J Pharm Sci20062927828716815001
   PubMed Web of Science ®Google Scholar
• PoutonCWLipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systemsEur J Pharm Sci200011S93S9811033431
   PubMed Web of Science ®Google Scholar
• PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov2007623124817330072
   PubMed Web of Science ®Google Scholar
• YangLChoiS-KShinH-JHanHK3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofenInt J Nanomedicine201384147415524204143
   PubMed Web of Science ®Google Scholar
• YangLShaoYHanHKImproved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complexInt J Pharm201447125826324834880
   PubMed Web of Science ®Google Scholar
• KesisoglouFPanmaiSWuYNanosizing – oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev20075963164417601629
   PubMed Web of Science ®Google Scholar
• RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov2004378579615340388
   PubMed Web of Science ®Google Scholar
• GuichardJPBlouquinPQingYA new formulation of fenofibrate: suprabioavailable tabletsCurr Med Res Opin20001613413810893657
   PubMed Web of Science ®Google Scholar
• SauronRWilkinsMJessentVDuboisAMaillotCWeilAAbsence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulationInt J Clin Pharmacol Ther200644647016502765
   PubMed Web of Science ®Google Scholar
• LiuYKathanKSaadWPrud’hommeRKOstwald ripening of β-carotene nanoparticlesPhys Rev Lett20079803610217358697
   PubMed Web of Science ®Google Scholar
• VermaSKumarSGokhaleRBurgessDJPhysical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripeningInt J Pharm201140614515221185926
   PubMed Web of Science ®Google Scholar
• ChaubalMVPopescuCConversion of nanosuspensions into dry powders by spray drying: a case studyPharm Res2008252302230818509597
   PubMed Web of Science ®Google Scholar
• Van EerdenbrughBFroyenLVan HumbeeckJMartensJAAugustijnsPVan den MooterGDrying of crystalline drug nanosuspensions – the importance of surface hydrophobicity on dissolution behavior upon redispersionEur J Pharm Sci20083512713518644441
   PubMed Web of Science ®Google Scholar
• CerdeiraAMMazzottiMGanderBFormulation and drying of miconazole and itraconazole nanosuspensionsInt J Pharm201344320922023291552
   PubMed Web of Science ®Google Scholar
• YangLShaoYHanHKPreparation and in vitro/in vivo characterization of tranilast-AMP clay complex for improving drug dissolution and bioavailabilityArch Pharm Res2014371554155925119994
   PubMedGoogle Scholar
• HarperCRJacobsonTAUsefulness of omega-3 fatty acids and the prevention of coronary heart diseaseAm J Cardiol2005961521152916310434
   PubMed Web of Science ®Google Scholar
• DaviglusMLStamlerJOrenciaAJFish consumption and the 30-year risk of fatal myocardial infarctionN Engl J Med1997336104610539091800
   PubMed Web of Science ®Google Scholar
• AscherioARimmEBStampferMJGiovannucciELWillettWCDietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among menN Engl J Med19953329779837885425
   PubMed Web of Science ®Google Scholar
• YangLShaoYHanHKDevelopment of omega-3 phospholipid-based solid dispersion of fenofibrate for the enhancement of oral bioavailabilityEur J Pharm Sci20157810311026165620
   PubMedGoogle Scholar
• ChenHLHwangJCSome comments on the degree of crystallinity defined by the enthalpy of meltingPolymer19953643554357
   Google Scholar
• JantratidEJanssenNChokshiHTangKDressmanJBDesigning biorelevant dissolution tests for lipid formulations: case example–lipid suspension of RZ-50Eur J Pharm Biopharm20086977678518226882
   PubMed Web of Science ®Google Scholar
• VogtMKunathKDressmanJBDissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparationsEur J Pharm Biopharm20086828328817574403
   PubMed Web of Science ®Google Scholar
• MunozAGuichardJPReginaultPMicronised fenofibrateAtherosclerosis1994110S45S487857384
   PubMedGoogle Scholar
• JamzadSFassihiRRole of surfactant and pH on dissolution properties of fenofibrate and glipizide – a technical noteAAPS Pharm-SciTech20067E17E22
   PubMed Web of Science ®Google Scholar
• GuayDRUpdate on fenofibrateCardiovasc Drug Rev20022028130212481201
   PubMed Web of Science ®Google Scholar
• Guivarc’hP-HVachonMGFordyceDA new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditionsClin Ther2004261456146915531008
   PubMed Web of Science ®Google Scholar
• OverhoffKAMcConvilleJTYangWJohnstonKPPetersJIWilliamsROIIIEffect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezingPharm Res20082516717517968635
   PubMed Web of Science ®Google Scholar
• ZuYWuWZhaoXEnhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation techniqueInt J Pharm201447136637624882039
   PubMed Web of Science ®Google Scholar
• ZuYLiNZhaoXIn vitro dissolution enhancement of micronized L-nimodipine by antisolvent re-crystallization from its crystal form HInt J Pharm20144641924456674
   PubMedGoogle Scholar
• StraussGSchurtenbergerPHauserHThe interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-dryingBiochim Biophys Acta19868581691803011090
   PubMed Web of Science ®Google Scholar
• MiyajimaKRole of saccharides for the freeze-thawing and freeze drying of liposomeAdv Drug Deliv Rev199724151159
   Web of Science ®Google Scholar
• GriffinBTKuentzMVertzoniMComparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrateEur J Pharm Biopharm20148642743724184675
   PubMed Web of Science ®Google Scholar
• CarrièreFRenouCLopezVThe specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test mealsGastroenterology200011994996011040182
   PubMed Web of Science ®Google Scholar
• WilliamsHDTrevaskisNYeapYYAnbyMUPoutonCWPorterCJLipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathwayPharm Res2013302976299223824582
   PubMed Web of Science ®Google Scholar
• Te BooyMPde RuiterRAde MeereALEvaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetryPharm Res199291091141589394
   PubMed Web of Science ®Google Scholar
• DattaKKulkarniCEswaramoorthyMAminoclay: a permselective matrix to stabilize copper nanoparticlesChem Commun201046616618
   PubMed Web of Science ®Google Scholar
• HanafyASpahn-LangguthHVergnaultGPharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drugAdv Drug Deliv Rev20075941942617566595
   PubMed Web of Science ®Google Scholar